SKBNF yields 35.71% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, SKBNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKBNF + JNJ for your $10,000?
Shikun & Binui Ltd., together with its subsidiaries, engages in the infrastructure and construction, real estate development, concessions, energy, and other businesses in Israel and internationally. It engages in building and maintaining infrastructure projects, including government and public facilities, educational and cultural institutions, medical facilities, courthouses, etc.; and development, construction, and operation of power generation facilities using photovoltaic (PV) systems, natural gas, thermo-solar technology, and wind and hydro facilities. The company also undertakes roads, highways, bridges, and water and wastewater treatment plants projects; and digging of tunnels and underpasses, and other works. In addition, it develops residential and commercial units; and rents properties, such as student dormitories, office buildings, and commercial spaces. The company was formerly known as Housing and Construction Holding Company Ltd. and changed its name to Shikun & Binui Ltd. in March 2009. The company was founded in 1920 and is headquartered in Airport City, Israel.
Full SKBNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.